Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Canine dilated cardiomyopathy drugs are used to treat heart muscle diseases, which cause the heart to weaken and enlarge. Canine dilated cardiomyopathy is prevalent in certain breeds of dogs and is observed to be rare in crossbreed dogs. Moreover, canine dilated cardiomyopathy drug treatment goals are achieved by the administration of cardiac medication which may be delivered through injections in an emergency or orally in stable animals.
The report details the trend, potential and market size of Canine Dilated Cardiomyopathy Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Canine Dilated Cardiomyopathy Drugsmarket, defines the market attractiveness level of Canine Dilated Cardiomyopathy Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Canine Dilated Cardiomyopathy Drugs industry, describes the types of Canine Dilated Cardiomyopathy Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Canine Dilated Cardiomyopathy Drugs market and the development prospects and opportunities of Canine Dilated Cardiomyopathy Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Canine Dilated Cardiomyopathy Drugs market in Chapter 13.
By Player:
Merck
Orion, Elanco
Elanco
KG, Merck & Co
Boehringer Ingelheim
Dechra Pharmaceuticals PLC, Zoetis Inc
CH Boehringer Sohn AG & Co
SAVA Vet
Bayer AG
By Type:
Angiotensin II Receptor Blockers (ARB)
Vasodilators
Cardiac Glycosides
Anti-arrhythmic
Pimobenden
Diuretics
ACE Inhibitors
By End-User:
Veterinary Clinics
Drug Stores
Online Pharmacies
Veterinary Hospitals
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Canine Dilated Cardiomyopathy Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Canine Dilated Cardiomyopathy Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Canine Dilated Cardiomyopathy Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Canine Dilated Cardiomyopathy Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Canine Dilated Cardiomyopathy Drugs Market Analysis and Outlook to 2022
-
7.1 Global Canine Dilated Cardiomyopathy Drugs Consumption (2017-2022)
-
7.2 United States Canine Dilated Cardiomyopathy Drugs Consumption (2017-2022)
-
7.3 Europe Canine Dilated Cardiomyopathy Drugs Consumption (2017-2022)
-
7.4 China Canine Dilated Cardiomyopathy Drugs Consumption (2017-2022)
-
7.5 Japan Canine Dilated Cardiomyopathy Drugs Consumption (2017-2022)
-
7.6 India Canine Dilated Cardiomyopathy Drugs Consumption (2017-2022)
-
7.7 South Korea Canine Dilated Cardiomyopathy Drugs Consumption (2017-2022)
8 Region and Country-wise Canine Dilated Cardiomyopathy Drugs Market Analysis and Outlook to 2028
-
8.1 Global Canine Dilated Cardiomyopathy Drugs Consumption Forecast (2022-2028)
-
8.2 United States Canine Dilated Cardiomyopathy Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Canine Dilated Cardiomyopathy Drugs Consumption Forecast (2022-2028)
-
8.4 China Canine Dilated Cardiomyopathy Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Canine Dilated Cardiomyopathy Drugs Consumption Forecast (2022-2028)
-
8.6 India Canine Dilated Cardiomyopathy Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Canine Dilated Cardiomyopathy Drugs Consumption Forecast (2022-2028)
9 Global Canine Dilated Cardiomyopathy Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Canine Dilated Cardiomyopathy Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Angiotensin II Receptor Blockers (ARB) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Vasodilators Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Cardiac Glycosides Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Anti-arrhythmic Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Pimobenden Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Diuretics Consumption and Growth Rate (2017-2022)
-
9.1.7 Global ACE Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Canine Dilated Cardiomyopathy Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Veterinary Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drug Stores Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Veterinary Hospitals Consumption and Growth Rate (2017-2022)
10 Global Canine Dilated Cardiomyopathy Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Canine Dilated Cardiomyopathy Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Angiotensin II Receptor Blockers (ARB) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Cardiac Glycosides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Anti-arrhythmic Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Pimobenden Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Diuretics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global ACE Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Canine Dilated Cardiomyopathy Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Veterinary Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Veterinary Hospitals Consumption Forecast and Growth Rate (2022-2028)
11 Global Canine Dilated Cardiomyopathy Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Canine Dilated Cardiomyopathy Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Canine Dilated Cardiomyopathy Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Canine Dilated Cardiomyopathy Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Canine Dilated Cardiomyopathy Drugs Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Canine Dilated Cardiomyopathy Drugs Product and Service
-
14.2 Orion, Elanco
-
14.2.1 Orion, Elanco Company Details
-
14.2.2 Orion, Elanco Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Orion, Elanco Canine Dilated Cardiomyopathy Drugs Product and Service
-
14.3 Elanco
-
14.3.1 Elanco Company Details
-
14.3.2 Elanco Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Elanco Canine Dilated Cardiomyopathy Drugs Product and Service
-
14.4 KG, Merck & Co
-
14.4.1 KG, Merck & Co Company Details
-
14.4.2 KG, Merck & Co Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 KG, Merck & Co Canine Dilated Cardiomyopathy Drugs Product and Service
-
14.5 Boehringer Ingelheim
-
14.5.1 Boehringer Ingelheim Company Details
-
14.5.2 Boehringer Ingelheim Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boehringer Ingelheim Canine Dilated Cardiomyopathy Drugs Product and Service
-
14.6 Dechra Pharmaceuticals PLC, Zoetis Inc
-
14.6.1 Dechra Pharmaceuticals PLC, Zoetis Inc Company Details
-
14.6.2 Dechra Pharmaceuticals PLC, Zoetis Inc Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Dechra Pharmaceuticals PLC, Zoetis Inc Canine Dilated Cardiomyopathy Drugs Product and Service
-
14.7 CH Boehringer Sohn AG & Co
-
14.7.1 CH Boehringer Sohn AG & Co Company Details
-
14.7.2 CH Boehringer Sohn AG & Co Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 CH Boehringer Sohn AG & Co Canine Dilated Cardiomyopathy Drugs Product and Service
-
14.8 SAVA Vet
-
14.8.1 SAVA Vet Company Details
-
14.8.2 SAVA Vet Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 SAVA Vet Canine Dilated Cardiomyopathy Drugs Product and Service
-
14.9 Bayer AG
-
14.9.1 Bayer AG Company Details
-
14.9.2 Bayer AG Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bayer AG Canine Dilated Cardiomyopathy Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Canine Dilated Cardiomyopathy Drugs
-
Figure Canine Dilated Cardiomyopathy Drugs Picture
-
Table Global Canine Dilated Cardiomyopathy Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Canine Dilated Cardiomyopathy Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Canine Dilated Cardiomyopathy Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Canine Dilated Cardiomyopathy Drugs Consumption by Country (2017-2022)
-
Figure United States Canine Dilated Cardiomyopathy Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Canine Dilated Cardiomyopathy Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Canine Dilated Cardiomyopathy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Canine Dilated Cardiomyopathy Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Canine Dilated Cardiomyopathy Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Canine Dilated Cardiomyopathy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Canine Dilated Cardiomyopathy Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Canine Dilated Cardiomyopathy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Canine Dilated Cardiomyopathy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Canine Dilated Cardiomyopathy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Canine Dilated Cardiomyopathy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Canine Dilated Cardiomyopathy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Canine Dilated Cardiomyopathy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Angiotensin II Receptor Blockers (ARB) Consumption and Growth Rate (2017-2022)
-
Figure Global Vasodilators Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiac Glycosides Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-arrhythmic Consumption and Growth Rate (2017-2022)
-
Figure Global Pimobenden Consumption and Growth Rate (2017-2022)
-
Figure Global Diuretics Consumption and Growth Rate (2017-2022)
-
Figure Global ACE Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Veterinary Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Veterinary Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Angiotensin II Receptor Blockers (ARB) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiac Glycosides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-arrhythmic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pimobenden Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diuretics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ACE Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Veterinary Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Veterinary Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Canine Dilated Cardiomyopathy Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Canine Dilated Cardiomyopathy Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Canine Dilated Cardiomyopathy Drugs Product and Service
-
Table Orion, Elanco (Foundation Year, Company Profile and etc.)
-
Table Orion, Elanco Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orion, Elanco Canine Dilated Cardiomyopathy Drugs Product and Service
-
Table Elanco (Foundation Year, Company Profile and etc.)
-
Table Elanco Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Elanco Canine Dilated Cardiomyopathy Drugs Product and Service
-
Table KG, Merck & Co (Foundation Year, Company Profile and etc.)
-
Table KG, Merck & Co Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table KG, Merck & Co Canine Dilated Cardiomyopathy Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Canine Dilated Cardiomyopathy Drugs Product and Service
-
Table Dechra Pharmaceuticals PLC, Zoetis Inc (Foundation Year, Company Profile and etc.)
-
Table Dechra Pharmaceuticals PLC, Zoetis Inc Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dechra Pharmaceuticals PLC, Zoetis Inc Canine Dilated Cardiomyopathy Drugs Product and Service
-
Table CH Boehringer Sohn AG & Co (Foundation Year, Company Profile and etc.)
-
Table CH Boehringer Sohn AG & Co Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table CH Boehringer Sohn AG & Co Canine Dilated Cardiomyopathy Drugs Product and Service
-
Table SAVA Vet (Foundation Year, Company Profile and etc.)
-
Table SAVA Vet Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table SAVA Vet Canine Dilated Cardiomyopathy Drugs Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Canine Dilated Cardiomyopathy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Canine Dilated Cardiomyopathy Drugs Product and Service
-
